Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Van Uden NOP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Post NF; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Ginski G; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Peters R; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Van Uden NOP; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Bekkenk MW; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, VU University, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands., Wolkerstorfer A; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Netea MG; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Luiten RM; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
Publikováno v:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2023 Sep; Vol. 36 (5), pp. 348-354. Date of Electronic Publication: 2023 Jun 09.
Autor:
van Duijn A; Laboratory of Experimental Dermatology, Department of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Willemsen KJ; Laboratory of Experimental Dermatology, Department of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., van Uden NOP; Laboratory of Experimental Dermatology, Department of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Hoyng L; Department of Oncogenomics, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Erades S; Laboratory of Experimental Dermatology, Department of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Koster J; Department of Oncogenomics, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Luiten RM; Laboratory of Experimental Dermatology, Department of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Bakker WJ; Laboratory of Experimental Dermatology, Department of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. w.j.bakker@amsterdamumc.nl.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Mar; Vol. 71 (3), pp. 529-540. Date of Electronic Publication: 2021 Jul 15.
Autor:
Willemsen M; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands. Electronic address: m.willemsen@amsterdamumc.nl., Post NF; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., van Uden NOP; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Narayan VS; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Chielie S; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Kemp EH; Department of Oncology and Metabolism, The Medical School, The University of Sheffield, Sheffield, United Kingdom., Bekkenk MW; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Luiten RM; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2022 Mar; Vol. 142 (3 Pt B), pp. 876-883.e3. Date of Electronic Publication: 2021 Jun 22.
Autor:
Levels MJ; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., Fehres CM; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., van Baarsen LGM; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., van Uden NOP; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., Germar K; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., O'Toole TG; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands., Blijdorp ICJ; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., Semmelink JF; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., Doorenspleet ME; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., Bakker AQ; AIMM Therapeutics, Amsterdam, the Netherlands., Krasavin M; Saint Petersburg State University, Saint Petersburg, Russian Federation., Tomilin A; Institute of Cytology, Russian Academy of Sciences, St-Petersburg, Russian Federation., Brouard S; Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France., Spits H; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; AIMM Therapeutics, Amsterdam, the Netherlands., Baeten DLP; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands., Yeremenko NG; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, the Netherlands. Electronic address: n.g.yeremenko@amsterdamumc.nl.
Publikováno v:
Journal of autoimmunity [J Autoimmun] 2019 Jul; Vol. 101, pp. 131-144. Date of Electronic Publication: 2019 Apr 30.